Correspondence 0001437749-25-006791 from Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc.
Date: March 10, 2025 · CIK: 0001617867 · Accession: 0001437749-25-006791
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285464
Letter
amix20250310_corresp.htm
Autonomix Medical, Inc.
21 Waterway Avenue, Suite 300
The Woodlands, Texas 77380
March 10, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Attention: Juan Grana
Re:
Autonomix Medical, Inc.
Registration Statement on Form S-3
Filed February 28, 2025
Registration No. 333-285464
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on March 11, 2025, or as soon thereafter as possible on such date.
Please direct any questions or comments concerning this request to Cavas Pavri of Arent Fox LLP at (202) 724-6847. Also, please notify Mr. Pavri when this request for acceleration has been granted.
Very truly yours,
Autonomix Medical, Inc.
Show Raw Text
CORRESP 1 filename1.htm amix20250310_corresp.htm Autonomix Medical, Inc. 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 March 10, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporate Finance Washington, DC 20549 Attention: Juan Grana Re: Autonomix Medical, Inc. Registration Statement on Form S-3 Filed February 28, 2025 Registration No. 333-285464 Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 P.M. (Eastern Time) on March 11, 2025, or as soon thereafter as possible on such date. Please direct any questions or comments concerning this request to Cavas Pavri of Arent Fox LLP at (202) 724-6847. Also, please notify Mr. Pavri when this request for acceleration has been granted. Very truly yours, Autonomix Medical, Inc. By: /s/ Trent Smith Name: Trent Smith Title: Chief Financial Officer